JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolfram, R. M.
Right arrow Articles by Sinzinger, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolfram, R. M.
Right arrow Articles by Sinzinger, H.

Radioiodine Therapy Induces Dose-Dependent In Vivo Oxidation Injury: Evidence by Increased Isoprostane 8-Epi-PGF2{alpha}

Roswitha M. Wolfram, MD1, Alexandra C. Budinsky, MS2, Barbara Palumbo, MD3, Renato Palumbo, MD3 and Helmut Sinzinger, MD4,5

1 Department of Angiology, University of Vienna, Vienna, Austria
2 Clinical Division of Oncology, Department of Internal Medicine I, University of Vienna, Vienna, Austria
3 Institute of Nuclear Medicine, University of Perugia, Perugia, Italy
4 Department of Nuclear Medicine, University of Vienna, Vienna, Austria
5 Wilhelm Auerswald Atherosclerosis Research Group (ASF) Vienna, Vienna, Austria



View larger version (24K):

[in a new window]
 
FIGURE 1. Kinetic of plasma 8-epi-PGF2{alpha} after radioiodine therapy. Dose-dependent increase in 8-epi-PGF2{alpha} is seen, with maximum at days 3 and 4 after therapy. Decline seems also to be dose dependent. D = day; W = week.

 


View larger version (23K):

[in a new window]
 
FIGURE 2. Kinetic of serum 8-epi-PGF2{alpha} after radioiodine therapy. Dose-dependent increase in 8-epi-PGF2{alpha} is seen, with maximum at days 3 and 4 after therapy. Decline seems also to be dose dependent. D = day; W = week.

 


View larger version (24K):

[in a new window]
 
FIGURE 3. Kinetic of urinary 8-epi-PGF2{alpha} after radioiodine therapy. Dose-dependent increase in 8-epi-PGF2{alpha} is seen, with maximum at days 3 and 4 after therapy. Decline seems also to be dose dependent. D = day; W = week.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.